Mounjaro Quickpen 12.5 mg once weekly 4 doses – 1 pen

Mounjaro (Tirzepatide) is a prescription medication used to treat adults with type 2 diabetes. It is also increasingly employed in weight management programs for individuals who are overweight or obese, as part of a comprehensive treatment plan including a healthy diet and regular exercise.

Each pen delivers 12.5 mg of the active ingredient Tirzepatide in a 2.4 ml volume. The pen is designed for simple, once-weekly administration at a dose determined by a physician.

✅ Features:

• Improves blood sugar control.

• Supports weight loss when used within a comprehensive treatment program.

• Suppresses appetite and prolongs satiety.

• Multi-use pen, convenient to carry and use.

• Suitable for once-weekly dosing.

🩺 Directions for Use:

• Dosage: As prescribed by your healthcare provider.

• Administration: Inject subcutaneously into the abdomen, thigh, or upper arm, once weekly.

• For use only under medical supervision.

⚠️ Warnings and Precautions:

• Not indicated during pregnancy or breastfeeding without medical advice.

• Monitor blood glucose levels regularly.

• May cause side effects such as nausea, diarrhea, or decreased appetite.

💡 Storage:

• Store refrigerated at 2–8°C (36–46°F).

• Do not freeze.

• Allow to reach room temperature before injection.

• Keep out of reach of children.